Cefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.
Elizabeth B. Hirsch, PharmD, RPh
Advertisement
Articles by Elizabeth B. Hirsch, PharmD, RPh
Advertisement
Latest Updated Articles
New Antibiotics Treat Select Resistant InfectionsPublished: May 21st 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
3
Disparities in Continuous Glucose Monitor Prescriptions by Language Preference Among Adults With Type 2 Diabetes
4
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
5
